ctrl K

Watchlist Price Alert

Agile Therapeutics Inc. (AGRX)

NASDAQ: AGRX · Real-Time Price · USD

1.51

0.05 (3.42%)

At close: Aug 22, 2024, 7:58 PM

Agile Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	19.59M	10.88M	4.1M	749K	n/a	n/a	n/a	n/a
Cost of Revenue	8.98M	6.84M	10.72M	282K	163K	23K	23K	19K
Gross Profit	10.62M	4.05M	-6.62M	467K	-163K	-23K	-23K	-19K
Operating Income	-19.88M	-41.43M	-71M	-49.05M	-18.86M	-19.54M	-26.81M	-29.72M
Interest Income	78K	80K	25K	309K	252K	366K	282K	117K
Pretax Income	-14.46M	-30.09M	-74.89M	-51.85M	-18.61M	-20.26M	-28.3M	-31.82M
Net Income	-14.46M	-25.41M	-76.58M	-54.69M	-18.44M	-19.78M	-28.3M	-28.74M
Selling & General & Admin	28.27M	42.23M	58.14M	36.02M	9M	8.74M	12.38M	8.79M
Research & Development	2.23M	3.25M	6.25M	13.5M	9.86M	9.78M	14.43M	20.93M
Other Expenses	n/a	4.29M	-5.3M	n/a	n/a	1.02M	n/a	n/a
Operating Expenses	30.5M	45.48M	64.39M	49.52M	18.86M	18.52M	26.81M	29.72M
Interest Expense	1.42M	3.13M	3.91M	3.11M	n/a	1.12M	1.92M	2.33M
Selling & Marketing Expenses	17.77M	30.37M	43.44M	23.29M	1.08M	942K	n/a	n/a
Cost & Expenses	39.48M	52.32M	75.11M	49.8M	18.86M	18.52M	26.81M	29.72M
Income Tax Expense	1.42M	-4.67M	1.69M	2.83M	-163K	-477K	1.92M	-3.08M
Shares Outstanding (Basic)	2.16M	432.22K	1.21K	42.34K	24.72K	17.16K	15.47K	14.14K
Shares Outstanding (Diluted)	2.16M	432.22K	1.21K	42.34K	24.72K	17.16K	15.47K	14.14K
EPS (Basic)	-6.71	-58.79	-63.12K	-1.29K	-746.2	-1.15K	-1.83K	-2.03K
EPS (Diluted)	-6.71	-58.79	-63.12K	-1.29K	-746.2	-1.15K	-1.83K	-2.03K
EBITDA	-19.88M	-39.9M	-64.93M	-48.47M	-18.61M	-19.54M	-26.51M	-29.72M
EBIT	-13.05M	-26.96M	-67.15M	-48.74M	n/a	-19.14M	-26.39M	-29.49M
Depreciation & Amortization	386K	1.53M	2.22M	276K	163K	23K	23K	19K